Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,866.03 3.72 0.20%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,417.53 -0.15 -0.00%
TOPIX 1,166.59 0.04 0.00%
HANG SENG 22,760.24 64.23 0.28%

Oculus Innovative Sciences Announces Fiscal First Quarter 2014 Financial Results and Conference Call



Oculus Innovative Sciences Announces Fiscal First Quarter 2014 Financial
Results and Conference Call

PETALUMA, Calif., July 31, 2013 (GLOBE NEWSWIRE) -- Oculus Innovative
Sciences, Inc. (Nasdaq:OCLS), today announced that the financial results for
its fiscal first quarter 2014, ended June 30, 2013, will be released after the
U.S. market closes on August 8, 2013. The earnings release will be followed by
a conference call at 1:30 p.m. PDT (4:30 p.m. EDT) on August 8, 2013, to
discuss fiscal first quarter results.

Individuals interested in participating in the conference call may do so by
dialing 877-303-7607 for domestic callers or 973-638-3203 for international
callers. Those interested in listening to the conference call live via the
Internet may do so at http://ir.oculusis.com/events.cfm. Please log on
approximately 30 minutes prior to the presentation in order to register and
download the appropriate software.

A telephone replay will be available for seven days following the conclusion
of the call by dialing 855-859-2056 for domestic callers, or 404-537-3406 for
international callers, and entering conference code 17450193. A webcast replay
will be available on the site at http://ir.oculusis.com/events.cfm for one
year following the call.

About Oculus Innovative Sciences

Oculus Innovative Science is a global healthcare company that designs,
manufactures and markets prescription and non-prescription products in 27
countries. The company's products are used to treat patients in
surgical/advanced wound management, dermatology, women's health and animal
health; addressing the unmet medical needs of these markets, while raising the
standard of patient care and lowering overall healthcare costs.  The company's
headquarters are in Petaluma, California, with manufacturing operations in the
United States and Latin America. More information can be found
at www.oculusis.com.

CONTACT: Media and Investor Contact:
        
         Oculus Innovative Sciences, Inc.
         Dan McFadden
         VP of Public and Investor Relations
         (425) 753-2105
         dmcfadden@oculusis.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement